PROK2 and colorectal carcinoma: In a colitis-associated CRC mouse model, Itatani et al. [119] demonstrated that the induction of colitis increased granulocyte colony stimulating factor (G-CSF) levels in anti-VEGF therapy-resistant tumors, which was associated with increased Bv8/PROK2+ neutrophil infiltration.